APA (7th ed.) Citation

Huang, Z., Li, Y., Zhao, H., & Zhao, B. Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade. BMC.

Chicago Style (17th ed.) Citation

Huang, Zhiyang, Yingying Li, Hong Zhao, and Bin Zhao. Mutation of Isocitrate Dehydrogenase Indicates Favorable Outcomes in Pan-cancer Immune Checkpoint Blockade. BMC.

MLA (9th ed.) Citation

Huang, Zhiyang, et al. Mutation of Isocitrate Dehydrogenase Indicates Favorable Outcomes in Pan-cancer Immune Checkpoint Blockade. BMC.